The largest database of trusted experimental protocols

6 protocols using formaldehyde

1

Immunocytochemistry of Fetoplacental Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fetoplacental ECs and villous stromal FBs were separately plated on
glass coverslips lining 24-well plates. At 90–100% confluence, cells were
fixed in 4% formaldehyde (Tousimis). After thorough washing with PBS, cells were
blocked with 2% BSA (Sigma) for 1 h at room temperature followed by incubation
in primary antibody at 4°C with slow shaking overnight. Cells were then
washed and then incubated with secondary antibody conjugated with AlexaFluor 488
(Invitrogen) for 1 h at room temperature. The glass coverslips were mounted to
glass slides using Lab Vision™ PermaFluor™ Aqueous Mounting Medium
(Thermo Scientific). Cells were then visualized using the Olympus FV1000
confocal fluorescence microscope. Primary antibodies: anti-CD31 (Sigma P8590;
1;200), anti-vimentin (Sigma V6630; 1:100), vWF (Sigma F3250; 1:400),
anti-α-smooth muscle antibody (Sigma A2547; 1:400), anti-chondroitin
proteoglycan sulfate 4 (Abcam ab129051; 1:100). Negative controls with
anti-mouse and anti-rabbit secondary antibodies alone were performed on both
cell types with no fluorescence visualize
+ Open protocol
+ Expand
2

Immunofluorescence Imaging of Cytoskeletal Structures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were grown in 12-well plates with 18-mm round coverslips until ∼80% confluent. Coverslips were washed with microtubule stabilizing buffer (MTSB; 100 mM 1,4-piperazinediethanesulfonic acid, pH 6.9, 30% glycerol, 1 mM ethylene glycol tetraacetic acid, and 1 mM MgSO4) and fixed with precooled methanol at −20°C for 5 min or 4% formaldehyde or 0.5% glutaraldehyde (Tousimis, Rockville, MD) in MTSB at room temperature for 10 min. glutaraldehyde was quenched with 0.2% NaBH4 for 20 min. Coverslips were washed twice with PBS and blocked in triton block (0.2 M glycine, 2.5% FBS, and 0.1% Triton X-100 in PBS) at 4°C. For formaldehyde and glutaraldehyde fixations, cells were preextracted with 0.5% Triton X-100 in MTSB for 1–5 min at 37°C. Primary antibody dilutions were as for immunoblots except for Bub1 (1:200), Aurora B (1:2500), and α-tubulin (YL1/2; 1:500). Images were acquired on a Nikon Eclipse Ti-E inverted fluorescence microscope using a CoolSNAP HQ2 camera and a 100×/1.4 numerical aperture (NA) oil objective. Chromosome spread images are from a single z. Other images are maximum projections of 0.2-μm z-stacks deconvolved using the AQI module in Nikon Elements unless otherwise indicated.
+ Open protocol
+ Expand
3

ChIP-seq of ATF4 Targets in MEFs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type or Atf4−/− MEFs (2 × 107) were fixed for 10 min in 1% formaldehyde (Tousimis), and this reaction was quenched by incubation for 5 min in 0.125 M glycine. Nuclear pellets were lysed in 10 mM Tris (pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% sodium deoxycholate, and 0.5% N-laurylsarcosine and sheared for 30 min (30 sec on, 30 sec off) in TPX microtubes using a Bioruptor bath sonicator (Diagenode). Complexes bearing ATF4 were captured with 5 µg of antibody (Santa Cruz Biotechnology, sc-200) bound to 50 µL of protein G Dynabeads (Life Technologies), washed five times in RIPA wash buffer (50 mM HEPES-KOH at pH 7.6, 300 mM lithium chloride, 1 mM EDTA, 1% NP-40 substitute, 0.7% sodium deoxycholate) and once in TE wash buffer (10 mM Tris at pH 8.0, 1 mM EDTA, 50 mM NaCl), and eluted in 0.1 M sodium bicarbonate/1% SDS. Cross-links were reversed by incubation overnight at 65°C followed by treatment with RNase A and proteinase K. DNA was isolated using PCR purification columns (Qiagen). Enrichment of ATF4 at target loci relative to input was determined by quantitative real-time PCR using the following primers: Sesn2 -3kb F (AGTGTTTGGTCAGGCAAGGT), Sesn2 -3kb R (TCAGTGGCTTTAACACGGCT), Sesn1 pr F (GATGACTGCTGGATTGCGGG), and Sesn1 pr R (AACCCTGCCGGTTCTTGTC).
+ Open protocol
+ Expand
4

Immunofluorescence Analysis of Cell-Derived Matrices

Check if the same lab product or an alternative is used in the 5 most similar protocols
After confirmation by bright-field microscopy of a uniform and intact
matrix, CDMs generated on glass coverslips were fixed for immunofluorescence
with 10% formaldehyde (Tousimis) at room temperature for 20 min. CDMs were then
washed three times with PBS, blocked with 30% (v/v) horse serum (Gibco) at room
temperature for 1 h. Thereafter, CDMs were incubated in primary antibody at room
temperature for 2 h and washed three times with PBS, followed by incubation with
secondary antibody conjugated with Alexa Fluor 488 (Invitrogen) for 1 h at room
temperature. Glass coverslips were then mounted on to glass slides once again
using Lab Vision™ PermaFluor™ Aqueous Mounting Medium, and the
Olympus FV1000 confocal fluorescent microscope was utilized once again to
visualize CDMs. Primary antibodies: anti-collagen I (Novus NB600-408; 1:200);
anti-fibronectin (Sigma F3648; 1:400). Negative controls with secondary antibody
alone were performed for CDM with no fluorescence visualized.
+ Open protocol
+ Expand
5

Quantifying HIV-1 Protein Expression Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
To quantify HIV-1 protein expression levels for different RNA species in the HIV-1Δenv-d2GFP A7 mutants as compared to RNA levels found in WT HIV-1Δenv-d2GFP, direct immunofluorescence by flow cytometry was used. At 20 hours after TNF-alpha induction, cells were fixed with a final of 2% formaldehyde (Tousimis. cat#1008A) for 15 min at room temperature. Cells were then centrifuged and supernatant aspirated. Cells were permeabilized with 1:1 methanol:acetone and incubated on ice for 10 min. Cells were then washed with Stain Buffer (DPBS without calcium and magnesium, 2% FBS, 2 mM EDTA, 0.1% IGEPAL CA-630) with centrifugation and supernatant aspiration between washes. Cells were centrifuged and supernatant aspirated and resuspended in 50 μL of Stain Buffer and 1 μL of KC57-RD1 (Beckman Coulter. cat#6604667) and incubated at room temperature in the dark for 15 minutes. Cells were then washed with 1 mL of Flow Buffer (DPBS without calcium and magnesium, 2% FBS, 2 mM EDTA) and centrifuged and supernatant aspirated. Cells were then resuspended in 200 μL of Flow Buffer. Fluorescence was detected using a LRSII flow cytometer (BD Biosciences) excitation at 531 nm, filtered at 585/42 nm, and recorded at 568–590 nm.
+ Open protocol
+ Expand
6

Quantifying Intracellular TG2 Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
For measurement of intracellular TG2 activity, 5-BP incorporation was visualized using fluorochrome-conjugated streptavidin HRP. Briefly, PASMCs grown on cover slips were serum-starved overnight and incubated with 5-BP (400 μM). Cells were then pretreated with MDC (200 μM) or vehicle for 30 minutes followed by 5-HT (1 μM) treatment for 1 hour. For negative control, 5-BP incubation was omitted. After a brief wash with PBS, cells were fixed with 4% formaldehyde (Tousimis, Rockville, MD) and permeabilized with 0.4% Triton X-100 in PBS. Permeabilized cells were then blocked with 5% BSA in PBS and incubated with Streptavidin AlexaFluor 555 HRP conjugate (Life Technologies) for 1 hour in blocking buffer. TG2 localization in permeabilized cells was visualized by incubating with anti-TG2 antibody and AlexaFluor® 488 conjugated secondary antibody (Life Technologies). Cover slips were mounted on to slides using Vectashield mounting medium with DAPI (Vector Labs, Burlingame, CA) and sealed. The stained cells were imaged under Axio light microscope (CarlZeiss AG) using Volocity software (PerkinElmer). TG2 activity was quantitated by measuring the 5-BP staining intensity per cell using ImageJ analysis software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!